Navin Fluorine just dropped a solid Q3FY26 investor presentation! **Business Performance:** Revenue surged 47% YoY to Rs. 892.4 Cr, with operating EBITDA rocketing 109% YoY to Rs. 307.6 Cr, boasting a 34.5% margin.

All segments fired: Specialty Chemicals revenue jumped 60%, HPP 35%, and CDMO a massive 61%. Nine-month performance also showed robust growth, with revenue up 44% and EBITDA up 114%. **Growth Drivers:** The company employs a '3P' approach (Product, Platform, Partnerships) to leverage its fluorochemicals expertise.

Strategic backward integration helps boost cost-efficiency and reduce import dependency. **Recent Developments:** Several key projects are progressing.

AHF capacity is commissioned, with additional HFC capacity and Dahej MPP de-bottlenecking targeted for Q3FY27. The Chemours project and Advanced Materials capacity are also advancing.

CDMO is successfully scaling up commercial supplies for EU majors. **Key Financial Metrics:** Strong top-line and bottom-line growth reflect robust demand and operational efficiency. **Management Outlook:** A positive demand outlook across all verticals, particularly in Specialty Chemicals and CDMO, supported by a constructive pricing environment for HFCs.

Ongoing capex programs underpin future expansion.